Terms: = Lung cancer AND PR, PGR, progesterone receptor AND Staging
39 results:
1. Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.
Xie Y; Lei C; Ma Y; Li Y; Yang M; Zhang Y; Law KN; Wang N; Qu S
BMC Womens Health; 2024 Jan; 24(1):16. PubMed ID: 38172874
[TBL] [Abstract] [Full Text] [Related]
2. [Expression and prognostic value of programmed cell death ligand 1 in patients with locally advanced and non-EGFR-mutated non-small cell lung cancer receiving concurrent chemoradiotherapy].
Xue WJ; Bi N; Yang L; Wang X; Dong JY; Zhang T; Wu LF; Wang LH
Zhonghua Yi Xue Za Zhi; 2022 Feb; 102(6):406-411. PubMed ID: 35144339
[No Abstract] [Full Text] [Related]
3. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features and prognosis of male breast cancer.
Wang X; Liu S; Xue Y
J Int Med Res; 2021 Oct; 49(10):3000605211049977. PubMed ID: 34713754
[TBL] [Abstract] [Full Text] [Related]
5. Clinical significance of detecting HDL and miR-103 levels in lung carcinoma patients.
Zhang Y; Zhang X; Han Z
J BUON; 2021; 26(4):1440-1445. PubMed ID: 34565002
[TBL] [Abstract] [Full Text] [Related]
6. Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival.
Fan Y; Wang Y; He L; Imani S; Wen Q
ESMO Open; 2021 Aug; 6(4):100232. PubMed ID: 34392135
[TBL] [Abstract] [Full Text] [Related]
7. [Prognostic factor analysis of patients with unresectablelung squamous cell carcinoma].
Gao X; Li Z; Shao XY; Liu XM; Liu C; Liu YP; Qu XJ; Zhang LY
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):569-573. PubMed ID: 34034477
[No Abstract] [Full Text] [Related]
8. Evaluation of disease staging and chemotherapeutic response in non-small cell lung cancer from patient tumor-derived metabolomic data.
Miller HA; Yin X; Smith SA; Hu X; Zhang X; Yan J; Miller DM; van Berkel VH; Frieboes HB
Lung Cancer; 2021 Jun; 156():20-30. PubMed ID: 33882406
[TBL] [Abstract] [Full Text] [Related]
9. [Operability and Pathological Response of Non-Small Cell lung cancer (NSCLC) after Neoadjuvant Therapy with Immune Checkpoint Inhibition].
Lücke E; Ganzert C; Föllner S; Wäsche A; Jechorek D; Schoeder V; Walles T; Genseke P; Schreiber J
Pneumologie; 2020 Nov; 74(11):766-772. PubMed ID: 32820489
[TBL] [Abstract] [Full Text] [Related]
10. Methylation of Glutathione-S-Transferase P1 Promotor in Egyptian Females with Breast cancer.
Moghazy TF; ElAttar HA; Eldeeb MK; Rashad RM; Farouk AM; Farag AM
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2523-2530. PubMed ID: 31450928
[TBL] [Abstract] [Full Text] [Related]
11. Using max standardized uptake value from positron emission tomography to assess tumor responses after lung stereotactic body radiotherapy for different prescriptions.
Ding M; Zollinger W; Ebeling R; Heard D; Posey R
J Appl Clin Med Phys; 2018 Nov; 19(6):226-233. PubMed ID: 30216639
[TBL] [Abstract] [Full Text] [Related]
12. A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
Falk RT; Staff AC; Bradwin G; Karumanchi SA; Troisi R
Cancer Causes Control; 2016 Aug; 27(8):1009-17. PubMed ID: 27357932
[TBL] [Abstract] [Full Text] [Related]
13. Metastatic large cell neuroendocrine carcinoma of the lung arising from the uterus: A pitfall in lung cancer diagnosis.
Ono K; Yokota NR; Yoshioka E; Noguchi A; Washimi K; Kawachi K; Miyagi Y; Kato H; Yokose T
Pathol Res Pract; 2016 Jul; 212(7):654-7. PubMed ID: 27113439
[TBL] [Abstract] [Full Text] [Related]
14. [Clinicopathological and prognostic significance of a panel of tumor biomarkers in lung adenocarcinoma: a tissue microarray study].
Yang X; Xue L; Guo L; Wen P; Lin D
Zhongguo Fei Ai Za Zhi; 2014 Mar; 17(3):243-53. PubMed ID: 24667263
[TBL] [Abstract] [Full Text] [Related]
15. Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer.
Chen X; Sun L; Cong Y; Zhang T; Lin Q; Meng Q; Pang H; Zhao Y; Li Y; Cai L; Dong X
J Exp Clin Cancer Res; 2014 Mar; 33(1):28. PubMed ID: 24628817
[TBL] [Abstract] [Full Text] [Related]
16. Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcus.
Blaauwgeers JL; Kappers I; Klomp HM; Belderbos JS; Dijksman LM; Smit EF; Postmus PE; Paul MA; Oosterhuis JW; Hartemink KJ; Vos CG; Burgers JA; Dahele M; Phernambucq EC; Witte BI; Thunnissen E
Virchows Arch; 2013 May; 462(5):547-56. PubMed ID: 23549732
[TBL] [Abstract] [Full Text] [Related]
17. Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of intrathoracic lymph node metastases from extrathoracic malignancies.
Sanz-Santos J; Cirauqui B; Sanchez E; Andreo F; Serra P; Monso E; Castellà E; Llatjós M; Mesa M; Ruiz-Manzano J; Rosell R
Clin Exp Metastasis; 2013 Apr; 30(4):521-8. PubMed ID: 23196318
[TBL] [Abstract] [Full Text] [Related]
18. A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer.
Cheng J; Ha M; Wang Y; Sun J; Chen J; Wang Y; Tong C
J Cancer Res Clin Oncol; 2012 Feb; 138(2):231-8. PubMed ID: 22102173
[TBL] [Abstract] [Full Text] [Related]
19. [Extranodal marginal zone non Hodgkin's lymphoma of the lung: a ten-year experience].
Milosević V; Bogdanović A; Janković S; Jovanović MP; Mihaljević B
Vojnosanit Pregl; 2011 Feb; 68(2):150-4. PubMed ID: 21456308
[TBL] [Abstract] [Full Text] [Related]
20. Initial experience with 18F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinoma.
Middendorp M; Maute L; Sauter B; Vogl TJ; Grünwald F
Ann Nucl Med; 2010 Jul; 24(6):441-6. PubMed ID: 20390384
[TBL] [Abstract] [Full Text] [Related]
[Next]
